Vitrolife AB
SE0000816043 · NASDAQ STOCKHOLM AB
3 directors and managers of Vitrolife AB have disclosed 7 transactions under MAR Article 19: 6 buys worth €519k and 1 sell worth €1.6M, which reads as net buying. The most recent disclosed transaction was on 2024-05-15. The largest buy was Thomas Axelsson (Chief Executive Officer (CEO)/Managing Directory) for €185k. See live cluster buys or start a free 14-day trial to get alerts when Vitrolife AB insiders trade.
Insiders
3
Net flow
€-1.1M
Bought
€519k
Sold
€1.6M
Buy Vitrolife AB
Pick a broker. We handle the signal, they handle execution.
Affiliate links — we may earn a referral fee if you sign up.
All disclosed transactions
| Date | Type | Insider | Shares | Price | Value |
|---|---|---|---|---|---|
| 2024-05-15 2y ago | BUY | Henrik Gustaf Knutsson Blomquist Member of the Board of Directors | 1,865 | €15.96 | €30k |
| 2024-05-14 2y ago | BUY | Henrik Gustaf Knutsson Blomquist Member of the Board of Directors | 9,135 | €15.52 | €142k |
| 2023-07-25 3y ago | BUY | Patrik Tolf Chief Financial Officer (CFO) | 2,000 | €14.57 | €29k |
| 2022-10-28 3y ago | BUY | Thomas Axelsson Chief Executive Officer (CEO)/Managing Directory | 12,000 | €15.40 | €185k |
| 2022-04-29 4y ago | BUY | Patrik Tolf Chief Financial Officer (CFO) | 2,000 | €21.56 | €43k |
| 2022-02-22 4y ago | BUY | Patrik Tolf Chief Financial Officer (CFO) | 3,500 | €25.87 | €91k |
| 2021-12-07 4y ago | SELL | Thomas Axelsson Chief Executive Officer (CEO)/Managing Directory | 38,300 | €42.56 | €1.6M |